You just read:

Therapix Biosciences and the Hannover Medical School Enter into an Investigator-initiated Clinical Trial Agreement to Assess the Effect of TXH-TS01 in Patients with Tourette Syndrome

News provided by

Therapix Biosciences Ltd

May 08, 2017, 08:30 ET